Miniaturizing Biology - The Rise of Lab-on-a-chip Technology
Over the past few decades, advances in microfabrication and microfluidic techniques have enabled the miniaturization of entire biology laboratories onto small silicon or glass chips known as "lab-on-a-chip" devices. These miniaturized devices allow biological and chemical analyses to be performed on tiny volumes of sample using microscale chambers, channels and detection systems integrated onto a single microchip. Some key advantages of lab-on-a-chip technology include portability, low cost of fabrication, high throughput capability and integration of multiple processing steps on a single platform.
Lab-on-a-chip systems can perform very basic assays like fluid mixing and chemical reactions as well as complex analyses like DNA sequencing and immunoassays. By leveraging microfluidics, these chips can precisely control fluid flow and mixing at microliter or even nanoliter volumes. This makes them well-suited for applications requiring small sample sizes like point-of-care testing, environmental monitoring and forensic analysis. When coupled with array technologies, lab-on-a-chip devices open up new possibilities for high-throughput screening and detection of multiple targets from a single small-volume sample.
Microarrays Revolutionize Genetic Analysis
One area where lab-on-a-chip technology has greatly impacted is in microarrays, also known as biochips. Microarrays allow thousands of genetic sequences, amino acid sequences or drug compounds to be placed onto a single microchip in an array format using micro-spotting techniques. By hybridizing a fluorescently labeled sample to the array, one can simultaneously detect and quantify the presence or amount of thousands of biopolymers like DNA or RNA sequences from that sample.
DNA microarrays were some of the earliest microarrays developed and helped drive the genomics revolution by enabling large-scale gene expression profiling and comparative genomic hybridization studies. Today, Lab-On-A-Chip And Microarrays (Biochip) let researchers screen genetic variations across entire genomes to identify disease-associated mutations and biomarkers. Clinical microarrays can detect genetic signatures of cancers, identify pathogens in biological samples and screen for hundreds of genetic disorders from a single test. Similarly, protein microarrays are being used to discover protein-protein interactions, autoantibody screening and biomarker discovery in diseases.
Going Smaller - Nanoarrays Push the Limits
The quest to analyze smaller samples with higher sensitivity has led to the development of nanoarray technology, capable of analyzing analytes at the single molecule level. Nanoarrays miniaturize traditional microarrays even further by fabricating nanoscale wells, pits or features to immobilize molecular probes via nanolithography techniques. The nanoscale confinement improves target specificity, reaction kinetics and allows lowering detection limits down to the single molecule.
One pioneering type of nanoarray is the nanohole array which comprises a thin metal or silicon film perforated with a regular array of nanometer sized holes. Each hole acts as an independent reaction chamber for probe immobilization. Nanohole arrays have demonstrated detection of DNA and proteins with zeptomolar (10-21 moles) sensitivity, orders of magnitude better than traditional microarrays. Other novel nanoarray formats include nanopost arrays, nanowells and arrays fabricated directly onto nanowires and carbon nanotubes. Integrated with lab-on-a-chip and microarrays (biochip), nanoarrays open up new vistas in ultrasensitive multiplexed biomarker detection and clinical diagnostics.
Future Prospects - Integrating Omics on a Chip
Looking ahead, the fields of lab-on-a-chip and microarrays (biochip) hold tremendous potential to transform health care diagnostics, biomedical research and environmental monitoring. There is immense scope to integrate multi-omic analysis like genomics, proteomics and metabolomics onto a single microfluidic chip. For example, lab-on-a-chip devices could extract nucleic acids and proteins from patient samples on-board, perform genome or transcriptome sequencing and protein microarray analysis, all on a single portable platform. This would allow comprehensive molecular profiling for precision medicine applications like cancer subtyping and monitoring disease progression or treatment response. We are also likely to see more widespread adoption of lab-on-a-chip and array technology into global health programs for resource-limited settings through portable, easy-to-use and low-cost diagnostic devices. Ultimately, continued convergence of microfabrication, microfluidics, arrays and automation promises to miniaturize entire biological analysis systems into "labs-on-chips" that can fit in the palm of one's hand.
Get more insights on lab-on-a-chip and microarrays (biochip)
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
Comments
0 comment